Related Experiment Video
Updated: Aug 14, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
[Hypertension and stroke: new publications in 2005]
1Medizinische Klinik, St.-Josefs-Hospital, Cloppenburg. j.schrader@kh-clp.de
Individual patient risk assessment is key for effective treatment, especially for atrial fibrillation patients. Achieving target blood pressure quickly significantly reduces stroke risk, with certain drug combinations proving more effective.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Context:
- European recommendations emphasize individualized patient risk evaluation over general therapeutic groupings.
- Primary and secondary prevention strategies for cardiovascular diseases are under continuous investigation.
- Atrial fibrillation and hypertension are significant risk factors for stroke and cardiovascular events.
Purpose:
- To evaluate the efficacy of different antihypertensive strategies in primary and secondary cardiovascular prevention.
- To compare the effectiveness of specific drug classes and treatment regimens in reducing stroke and cardiovascular events.
- To reinforce the importance of individualized risk assessment and timely blood pressure control.
Summary:
- Individualized risk assessment surpasses general therapeutic groups for patient management.
- Losartan shows greater benefit than atenolol in atrial fibrillation patients, highlighting blood pressure reduction's importance for stroke risk.
- Achieving target blood pressure within six months yields the greatest benefit.
- Combining calcium antagonists with ACE inhibitors is more effective at preventing strokes than beta blockers with diuretics.
- In secondary prevention, sartans outperform nitrendipine in preventing cardiovascular events.
Impact:
- Findings support personalized medicine approaches in cardiovascular disease management.
- Highlights the critical role of prompt and effective blood pressure control in stroke prevention.
- Provides evidence-based guidance for selecting antihypertensive drug combinations for optimal patient outcomes.
- Informs clinical practice and future research directions in cardiovascular pharmacotherapy.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management